ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.771,88
-3,15%
S&P 500
5.872,16
-2,95%
US Dollar vs BRL
6,2939
0,06%
Bitcoin
101.349,99
1,28%
Brent Oil
72,475
-0,36%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Austrália
  5. ASX
  6. Donaco International Ltd (DNA)

  7. Donaco International Ltd (DNA) Notícias

DNA

Donaco (DNA)

Donaco International Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:ASX:DNA
DataHoraFonteTítuloCódigoCompanhia
10/11/201521:52The Motley FoolPacker backs Crown Resorts Ltd with $200 million betASX:DNADonaco International Ltd
27/03/200912:13Dow Jones NewsUPDATE: FDA 'Unclear' If Avastin Data Backs Expanded ApprovalNYSE:DNAGenentech Inc. (Delisted 3/27/09)
27/03/200911:35Dow Jones NewsFDA 'Unclear' If Genentech Drug Data Backs Expanded ApprovalNYSE:DNAGenentech Inc. (Delisted 3/27/09)
26/03/200906:23Dow Jones NewsUPDATE: Roche Effectively Seals $46.8 Billion Genentech TakeoverNYSE:DNAGenentech Inc.
26/03/200904:05Dow Jones NewsRoche Completes Genentech Takeover, Holds 93.2%NYSE:DNAGenentech Inc.
26/03/200903:37Dow Jones NewsRoche Completes Tender Offer For Genentech, Holds 93.2%NYSE:DNAGenentech Inc.
25/03/200909:44Dow Jones News2nd UPDATE: Ethos Recommends UBS Holders Reject New Pay PlanNYSE:DNAGenentech Inc.
25/03/200907:43Dow Jones NewsUPDATE: Ethos Recommends UBS Holders Reject New Pay Plan At AGMNYSE:DNAGenentech Inc.
24/03/200915:08Dow Jones NewsRoche Says RiskMetrics Backs Genentech Takeover At $95/ShareNYSE:DNAGenentech Inc.
19/03/200914:09Dow Jones NewsEU Panel Backs Novartis' Glivec In Kit-positive GISTNYSE:DNAGenentech Inc.
18/03/200910:55Dow Jones NewsRoche Shares Down On Actemra; Herceptin Success Of Little HelpNYSE:DNAGenentech Inc.
18/03/200904:16Dow Jones NewsRoche's Herceptin Extends Life In Aggressive Stomach CancerNYSE:DNAGenentech Inc.
18/03/200903:33Dow Jones NewsRoche: Herceptin Prolongs Life In Stomach CancerNYSE:DNAGenentech Inc.
18/03/200901:32Dow Jones NewsUPDATE: Chugai,Roche Face Arthritis Drug Side Effect SetbackNYSE:DNAGenentech Inc.
17/03/200922:05Dow Jones NewsChugai:Undeniable Actemra Side Effects Tied To Patient DeathsNYSE:DNAGenentech Inc.
17/03/200919:54Dow Jones NewsBiotechnology Group Praises Biologic Drugs BillNYSE:DNAGenentech Inc.
17/03/200917:29Dow Jones News5th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayNYSE:DNAGenentech Inc.
17/03/200916:25Dow Jones News4th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayNYSE:DNAGenentech Inc.
17/03/200914:53Dow Jones News3rd UPDATE: Pfizer Launches $13.5 Billion Bond Offer; Pricing TuesdayNYSE:DNAGenentech Inc.
17/03/200914:01Dow Jones News2ndUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayNYSE:DNAGenentech Inc.
17/03/200913:13Dow Jones NewsUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayNYSE:DNAGenentech Inc.
16/03/200917:57Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&ANYSE:DNAGenentech Inc.
16/03/200915:49Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&ANYSE:DNAGenentech Inc.
16/03/200903:37Dow Jones NewsRoche Acquires Innovatis AG For EUR15 MillionNYSE:DNAGenentech Inc.
13/03/200909:45Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNYSE:DNAGenentech Inc.
12/03/200916:15Dow Jones NewsUS Antitrust Review May Not Pose Threat To Drug Co MergersNYSE:DNAGenentech Inc.
12/03/200911:06Dow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionNYSE:DNAGenentech Inc.
12/03/200908:10Dow Jones News4th UPDATE: Roche Seals $46.8 Billion Genentech DealNYSE:DNAGenentech Inc.
12/03/200905:32Dow Jones News3rd UPDATE: Roche Seals $46.8 Billion Genentech DealNYSE:DNAGenentech Inc.
12/03/200904:49Dow Jones NewsRoche Chairman: Friendly Deal With Genentech Cuts Out UncertaintyNYSE:DNAGenentech Inc.
 Apresentando as notícias mais relevantes sobre:ASX:DNA

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
AMOB3
Automob Participacoes ON
BOV
GPIV33
Gp Investments
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
PRIO3
PETRORIO ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
CVCB3
CVC BRASIL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados